Novel Biomarkers to Assess In-Utero Effects of Maternal Opioid Use: First Steps towards Understanding Short and Long Term Neurodevelopmental Sequelae

Maternal opioid use disorder is common, resulting in significant neonatal morbidity and cost. Currently, it is not possible to predict which opioid-exposed newborns will require pharmacotherapy for neonatal abstinence syndrome. Further, little is known regarding the effects of maternal opioid use di...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Genes Brain Behav
Prif Awduron: Goetzl, Laura, Thompson-Felix, Tara, Darbinian, Nune, Merabova, Nana, Merali, Salim, Merali, Carmen, Sanserino, Kathryne, Tatevosian, Tamara, Fant, Bruno, Wimmer, Mathieu E
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2019
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7074845/
https://ncbi.nlm.nih.gov/pubmed/31119847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/gbb.12583
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg